Monday, December 2, 2019

Investigational drugs reduce risk of death from Ebola virus disease

The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the investigational treatment ZMapp. The new report also shows that early diagnosis and treatment are associated with an increased likelihood of survival from EVD.

from Top Health News -- ScienceDaily https://ift.tt/35TMfZZ
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

One tiny mutation may explain how bat viruses become human threats

Scientists found that one tiny genetic change can completely alter how a coronavirus behaves in different species. Comparing SARS-CoV-2 with...